Positron Emission Tomography (PET) Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Positron Emission Tomography (PET) Market Overview

The global Positron Emission Tomography (PET) market is experiencing substantial growth, fueled by technological advancements in imaging, increasing adoption of personalized medicine, and the rising prevalence of cancers and cardiovascular diseases. By 2025, the PET market is projected to reach 2.6 billion USD, with a compound annual growth rate (CAGR) estimated between 5% to 6% from 2025 to 2030. PET technology plays a crucial role in providing functional imaging for diagnosing a wide range of conditions, particularly oncology, cardiology, and neurology.

Market Size

The PET market is witnessing steady growth, driven by the growing demand for non-invasive diagnostic tools that offer both functional and anatomical imaging. PET is increasingly integrated with other imaging modalities, such as CT and MRI, to provide more comprehensive diagnostic capabilities. This market is expected to grow at a CAGR of 5% to 6% through 2030, as healthcare facilities seek advanced imaging solutions to enhance diagnostic accuracy and improve patient outcomes.

Market Share & Trends Analysis

By Application

The PET market is segmented by application into the following key areas:

• Hospitals: Hospitals represent the largest segment of the PET market. PET systems are widely used in oncology for tumor detection, in cardiology for assessing heart function, and in neurology for brain imaging. This segment is expected to grow at a CAGR of 5% to 6%, as hospitals increasingly adopt PET technology for early and precise diagnostics.
• Diagnostic Imaging Centers: These centers use PET for outpatient diagnostics, offering specialized imaging services for various conditions, including cancers and neurological disorders. The segment is projected to experience a CAGR of 4% to 5%, as outpatient care becomes more widespread.
• Academic & Research Institutes: PET technology is also extensively used in research settings, where it helps with drug development, clinical studies, and brain research. The growth rate for this segment is expected to be around 5% to 6%, driven by continued investments in medical research and innovation.

By Product Type

The PET market is categorized by product type into the following systems:

• PET/CT Systems: These hybrid systems combine the functional imaging of PET with the anatomical imaging of CT, providing a more accurate and comprehensive diagnostic approach. PET/CT systems are the most widely used in clinical practice and are expected to grow at a CAGR of 5% to 6%, driven by their enhanced diagnostic accuracy.
• PET/MRI Systems: Combining PET with MRI, these hybrid systems offer superior soft tissue imaging, particularly beneficial in neurology and oncology. The PET/MRI systems segment is anticipated to experience a higher growth rate, with a CAGR of 6% to 7%, as demand for high-resolution imaging in neurological and oncological applications rises.
• Standalone PET Systems: These systems are dedicated to PET imaging and are primarily used in specialized diagnostic settings or smaller clinics. The standalone PET systems segment is projected to grow at a more moderate pace, with a CAGR of 4% to 5%.

By Key Players

The PET market is highly competitive, with several key players contributing to its growth:

• GE Healthcare: GE Healthcare is a leading provider of PET/CT and PET/MRI systems, known for its advanced imaging solutions that combine high-quality imaging with ease of use. Their systems are widely adopted in hospitals, research institutions, and diagnostic centers globally.
• Siemens Healthineers: Siemens Healthineers offers a range of cutting-edge PET/CT and PET/MRI systems, providing integrated solutions for various diagnostic and clinical needs. Their systems are recognized for their accuracy, efficiency, and flexibility in clinical settings.
• Koninklijke Philips N.V.: Philips specializes in hybrid imaging systems, including PET/CT and PET/MRI, and is known for its patient-centric designs and innovative imaging technologies that improve diagnostic confidence.
• Canon: Canon provides advanced imaging systems, including PET/CT and standalone PET systems, with a focus on high image quality, reliability, and operational efficiency, making their systems ideal for hospitals and research institutes.
• Mediso: Mediso is a key player in the PET market, offering both PET/CT and standalone PET systems that deliver high-resolution images and fast scan times, catering to both clinical and research applications.
• PerkinElmer: PerkinElmer specializes in PET imaging systems for both clinical diagnostics and preclinical research. Their focus on high sensitivity and precise image quality makes them a popular choice among healthcare providers and research institutions.
• Bruker: Bruker provides PET systems for both clinical and preclinical applications, emphasizing high-resolution imaging and advanced analytics. Their products are widely used in research settings, particularly in neuroscience and oncology studies.
• Shimadzu Corporation: Shimadzu offers a range of PET imaging solutions that deliver high-quality diagnostic imaging while ensuring ease of use and efficient workflow for healthcare facilities.
• Positron Corporation: Positron Corporation specializes in innovative PET imaging technologies, focusing on cost-effective solutions and accessibility for smaller medical institutions and diagnostic centers.
• Shanghai United Imaging Healthcare: This emerging player focuses on providing cutting-edge PET imaging solutions, particularly for the Chinese market, with a focus on technological innovation and cost-effective products.
• SinoUnion Healthcare: SinoUnion Healthcare provides a range of PET imaging products, including both standalone and hybrid systems, offering competitive solutions for both clinical and research applications in China and other emerging markets.

Opportunities & Challenges

Opportunities

• Technological Advancements: Ongoing improvements in PET imaging technology, including higher resolution detectors, faster scan times, and the integration of AI-based image processing, present opportunities to enhance diagnostic capabilities and efficiency.
• Rising Demand for Personalized Medicine: As personalized medicine becomes more prevalent, PET technology's ability to provide functional imaging for tailored treatment plans presents significant growth opportunities.
• Expansion in Emerging Markets: Increasing healthcare investments in emerging economies, coupled with the rising demand for advanced diagnostic tools, offer significant growth potential for PET system manufacturers in these regions.

Challenges

• High Equipment Costs: The high cost of PET systems and their maintenance can be a barrier to adoption in cost-sensitive regions, limiting their market penetration in some areas.
• Regulatory Hurdles: The complex regulatory requirements for medical imaging devices can delay product approvals and limit the speed at which new technologies are brought to market.
• Competition from Other Imaging Modalities: The growth of other imaging technologies, such as MRI and CT, which offer different advantages in certain applications, may limit the market share of PET systems in some clinical settings.